These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23200303)

  • 21. Safety, tolerability and subject-rated effects of acute intranasal cocaine administration during atomoxetine maintenance.
    Stoops WW; Blackburn JW; Hudson DA; Hays LR; Rush CR
    Drug Alcohol Depend; 2008 Jan; 92(1-3):282-5. PubMed ID: 17719727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence.
    Winhusen T; Somoza E; Ciraulo DA; Harrer JM; Goldsmith RJ; Grabowski J; Coleman FS; Mindrum G; Kahn R; Osman S; Mezinskis J; Li SH; Lewis D; Horn P; Montgomery MA; Elkashef A
    Drug Alcohol Depend; 2007 Dec; 91(2-3):141-8. PubMed ID: 17629631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: A placebo-controlled Italian study.
    Dell'Agnello G; Maschietto D; Bravaccio C; Calamoneri F; Masi G; Curatolo P; Besana D; Mancini F; Rossi A; Poole L; Escobar R; Zuddas A;
    Eur Neuropsychopharmacol; 2009 Nov; 19(11):822-34. PubMed ID: 19716683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.
    Mancino MJ; McGaugh J; Chopra MP; Guise JB; Cargile C; Williams DK; Thostenson J; Kosten TR; Sanders N; Oliveto A
    J Clin Psychopharmacol; 2014 Apr; 34(2):234-9. PubMed ID: 24525654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trial.
    McElroy SL; Guerdjikova A; Kotwal R; Welge JA; Nelson EB; Lake KA; Keck PE; Hudson JI
    J Clin Psychiatry; 2007 Mar; 68(3):390-8. PubMed ID: 17388708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized clinical trial of disulfiram for cocaine dependence or abuse during buprenorphine treatment.
    Schottenfeld RS; Chawarski MC; Cubells JF; George TP; Lappalainen J; Kosten TR
    Drug Alcohol Depend; 2014 Mar; 136():36-42. PubMed ID: 24462581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Placebo-controlled trial of atomoxetine for weight reduction in people with schizophrenia treated with clozapine or olanzapine.
    Ball MP; Warren KR; Feldman S; McMahon RP; Kelly DL; Buchanan RW
    Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):17-25. PubMed ID: 21459735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
    Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
    Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA; Kampman KM; Lynch KG; Pettinati HM; O'Brien CP
    Neuropsychopharmacology; 2005 Jan; 30(1):205-11. PubMed ID: 15525998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A placebo-controlled screening trial of celecoxib for the treatment of cocaine dependence.
    Reid MS; Angrist B; Baker S; Woo C; Schwartz M; Montgomery A; Majewska D; Robinson J; Rotrosen J
    Addiction; 2005 Mar; 100 Suppl 1():32-42. PubMed ID: 15730348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease.
    Weintraub D; Mavandadi S; Mamikonyan E; Siderowf AD; Duda JE; Hurtig HI; Colcher A; Horn SS; Nazem S; Ten Have TR; Stern MB
    Neurology; 2010 Aug; 75(5):448-55. PubMed ID: 20679638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended-Release Mixed Amphetamine Salts vs Placebo for Comorbid Adult Attention-Deficit/Hyperactivity Disorder and Cocaine Use Disorder: A Randomized Clinical Trial.
    Levin FR; Mariani JJ; Specker S; Mooney M; Mahony A; Brooks DJ; Babb D; Bai Y; Eberly LE; Nunes EV; Grabowski J
    JAMA Psychiatry; 2015 Jun; 72(6):593-602. PubMed ID: 25887096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, double-blind, placebo-controlled trial of venlafaxine for the treatment of depressed cocaine-dependent patients.
    Raby WN; Rubin EA; Garawi F; Cheng W; Mason E; Sanfilippo L; Lord S; Bisaga A; Aharonovich E; Levin F; McDowell D; Nunes EV
    Am J Addict; 2014; 23(1):68-75. PubMed ID: 24313244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder.
    Biederman J; Heiligenstein JH; Faries DE; Galil N; Dittmann R; Emslie GJ; Kratochvil CJ; Laws HF; Schuh KJ;
    Pediatrics; 2002 Dec; 110(6):e75. PubMed ID: 12456942
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topiramate for the treatment of cocaine addiction: a randomized clinical trial.
    Johnson BA; Ait-Daoud N; Wang XQ; Penberthy JK; Javors MA; Seneviratne C; Liu L
    JAMA Psychiatry; 2013 Dec; 70(12):1338-46. PubMed ID: 24132249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atomoxetine improved attention in children and adolescents with attention-deficit/hyperactivity disorder and dyslexia in a 16 week, acute, randomized, double-blind trial.
    Wietecha L; Williams D; Shaywitz S; Shaywitz B; Hooper SR; Wigal SB; Dunn D; McBurnett K
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):605-13. PubMed ID: 24206099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial of buprenorphine for treatment of concurrent opiate and cocaine dependence.
    Montoya ID; Gorelick DA; Preston KL; Schroeder JR; Umbricht A; Cheskin LJ; Lange WR; Contoreggi C; Johnson RE; Fudala PJ
    Clin Pharmacol Ther; 2004 Jan; 75(1):34-48. PubMed ID: 14749690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms.
    Oliveto A; Poling J; Mancino MJ; Williams DK; Thostenson J; Pruzinsky R; Gonsai K; Sofuoglu M; Gonzalez G; Tripathi S; Kosten TR
    Addiction; 2012 Jan; 107(1):131-41. PubMed ID: 21707811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial of atomoxetine for cognitive dysfunction in early Huntington disease.
    Beglinger LJ; Adams WH; Paulson H; Fiedorowicz JG; Langbehn DR; Duff K; Leserman A; Paulsen JS
    J Clin Psychopharmacol; 2009 Oct; 29(5):484-7. PubMed ID: 19745649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of atomoxetine on Tanner stage sexual development in children and adolescents with attention deficit/hyperactivity disorder: 18-month results from a double-blind, placebo-controlled trial.
    Trzepacz PT; Spencer TJ; Zhang S; Bangs ME; Witte MM; Desaiah D
    Curr Med Res Opin; 2011; 27 Suppl 2():45-52. PubMed ID: 21973230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.